NantOmics Buys OncoPlex Diagnostics

Los Angeles-based molecular diagnostics company NantOmics, which is one of the group of companies owned by biotech billionaire Patrick Soon Shiong, said Thursday that it has acquired OncoPlex Diagnostics, which is an accredited clinical laboratory focused on testing tumor cell proteins using mass spectrometry analysis. Financial termsd of the acquisition were not disclosed. NantWorks, the umbrella company for Soon Shiong's many ventures, already held a stack in OncoPlex, having first invested in the company in 2008. OncoPlex Diagnostics is absed in Rockville, Maryland, and provides services which helps with profiling the tumors of cancer patients. NantOmics is using molecular profiling to help doctors better treat cancer patients.